Comparative Evaluation of the Efficiency of Prostatotropic Agents of Natural Origin in Experimental Benign Prostatic Hyperplasia

By Borovskaya T.  

Bulletin of Experimental Biology and Medicine, Vol. 155, Iss. 1, 2013-05 ,pp. : 67-70

Springer Publishing Company

Access to resources Recommend Favorite

Phytoadaptogen correction of clinical and immunobiological parameters in patients with benign prostatic hyperplasia

By Bocharova O.   Matveev V.   Karpova R.   Aksyonov A.   Gorozhanskaya E.   Chebotaryov F.   Katosova L.   Platonova V.   Bochkov N.  

Bulletin of Experimental Biology and Medicine, Vol. 141, Iss. 5, 2006-05 ,pp. : 616-619

Springer Publishing Company

Access to resources Recommend Favorite

Benign prostate hyperplasia and stem cells: a new therapeutic opportunity

By Notara Maria  

Cell Biology and Toxicology, Vol. 28, Iss. 6, 2012-12 ,pp. : 435-442

Springer Publishing Company

Access to resources Recommend Favorite

Morphometric Evaluation of Vascularization of Hepatic Focal Nodular Hyperplasia

By Shchyogolev A.   Tumanova U.   Dubova E.  

Bulletin of Experimental Biology and Medicine, Vol. 156, Iss. 2, 2013-12 ,pp. : 266-270

Springer Publishing Company

Access to resources Recommend Favorite

Prooxidant-Antioxidant Balance in the Prostate and Blood of Rats with Sulpyride-Induced Prostatic Hyperplasia Corrected with Prostatilen

By Belostotskaya L.   Gomon O.   Nikitchenko Yu.   Chaika L.   Bondar’ V.   Dzyuba V.  

Bulletin of Experimental Biology and Medicine, Vol. 139, Iss. 3, 2005-03 ,pp. : 334-336

Springer Publishing Company

Access to resources Recommend Favorite